Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback